Meeting
2022 ASCO Annual Meeting
Cascade testing of first-degree relatives of patients with pancreatic cancer with confirmed germline genetic mutations: A simulation modeling study.
Authors
Mary Linton Bounetheau Peters
Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA
Mary Linton Bounetheau Peters , Barak Davidi , Claudia L. Seguin , Andrew Eckel , Pari Pandharipande
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10513)
DOI
10.1200/JCO.2022.40.16_suppl.10513
Abstract #
10513
Poster Bd #
392
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The GENetic Education, Risk Assessment and TEsting (GENERATE) study.
First Author: Matthew B. Yurgelun
Poster
2019 ASCO Annual Meeting
Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The genetic education, risk assessment and testing (GENERATE) study.
First Author: Matthew B. Yurgelun
Poster
2017 ASCO Annual Meeting
Expanded yield of multiplex panel testing in fully accrued prospective trial.
First Author: Gregory Idos
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Germline pathogenic variants among Mexican patients with adenocarcinoma of the pancreas.
First Author: Jose Luis Rodriguez Olivares